New discoveries in the basic science understanding of Peyronie’s disease

[1]  A. Kadıoğlu,et al.  Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfuntion , 2004, International Journal of Impotence Research.

[2]  J. Rajfer,et al.  Gene Transfer of Inducible Nitric Oxide Synthase Complementary DNA Regresses the Fibrotic Plaque in an Animal Model of Peyronie's Disease1 , 2004, Biology of reproduction.

[3]  A. Qian,et al.  Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. , 2004, Urology.

[4]  Stephen A Boorjian,et al.  Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. , 2004, The Journal of urology.

[5]  T. Shankey,et al.  Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease , 2004, International Journal of Impotence Research.

[6]  M. Ferrini,et al.  L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. , 2003, Nitric oxide : biology and chemistry.

[7]  E. Domann,et al.  Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques. , 2003, The Journal of urology.

[8]  G. Lin,et al.  Wogonin suppresses cellular proliferation and expression of monocyte chemoattractant protein 1 in Peyronie's plaque‐derived cells , 2003, BJU International.

[9]  H. Hackstein,et al.  Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. , 2003, The Journal of urology.

[10]  J. Mulhall.  Expanding the paradigm for plaque development in Peyronie's disease , 2003, International Journal of Impotence Research.

[11]  M. Ferrini,et al.  Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease , 2003, BJU international.

[12]  George Bou-Gharios,et al.  Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. , 2002, Nitric oxide : biology and chemistry.

[13]  T. Lue.  Peyronie's disease: an anatomically-based hypothesis and beyond , 2002, International Journal of Impotence Research.

[14]  G. Lin,et al.  Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease. , 2002, Biochemical and biophysical research communications.

[15]  M. Ferrini,et al.  Antifibrotic role of inducible nitric oxide synthase. , 2002, Nitric oxide : biology and chemistry.

[16]  J. Rajfer,et al.  Gene expression profiles in the Peyronie's disease plaque. , 2002, Urology.

[17]  T. H. Klotz,et al.  The prevalence of Peyronie's disease: results of a large survey , 2001, BJU international.

[18]  W. Hellstrom,et al.  Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. , 2001, Journal of andrology.

[19]  M. Schmidt,et al.  Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.

[20]  R. Dahiya,et al.  Microsatellite alterations and loss of heterozygosity in Peyronie's disease. , 2000, The Journal of urology.

[21]  W. Hellstrom,et al.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. , 2000, The Journal of urology.

[22]  R. Dahiya,et al.  The effect of surgical trauma on rat tunica albuginea. , 1998, The Journal of urology.

[23]  R. Dahiya,et al.  An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. , 1997, The Journal of urology.

[24]  E. Nucera,et al.  Immunologic findings in Peyronie's disease: a controlled study. , 1997, Urology.

[25]  R. Dahiya,et al.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. , 1997, The Journal of urology.

[26]  J. Jarow,et al.  Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. , 1997, The Journal of urology.

[27]  G. Jordan,et al.  Proposal: trauma as the cause of the Peyronie's lesion. , 1996, The Journal of urology.

[28]  G. Bottazzo,et al.  The genetic and bacteriological aspects of Peyronie's disease. , 1997, The Journal of urology.

[29]  K. Somers,et al.  Fibrin deposition in Peyronie's disease plaque. , 1997, The Journal of urology.

[30]  S. Wahl.  Inflammation and growth factors. , 1997, The Journal of urology.

[31]  T. Lue,et al.  The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. , 1997, The Journal of urology.

[32]  A. Modica,et al.  Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction. , 1996, Journal of andrology.

[33]  S. I. Chung,et al.  Factors That Control Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.

[34]  G. Mueller‐Eckhardt,et al.  HLA antigens in Peyronie's disease. , 1994, Urologia internationalis.

[35]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[36]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[37]  P. Grambsch,et al.  The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. , 1991, The Journal of urology.

[38]  G. Mueller‐Eckhardt,et al.  HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis? , 1991, Tissue antigens.

[39]  F. Dorey,et al.  The natural history of Peyronie's disease. , 1990, The Journal of urology.

[40]  A. Zachary,et al.  The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins. , 1987, Cleveland Clinic journal of medicine.

[41]  G. Wright,et al.  Chromosome abnormalities in Peyronie's disease. , 1987, The Journal of urology.

[42]  J. Pryor,et al.  Factors associated in the aetiology of peyronie's disease. , 1982, British journal of urology.

[43]  L. Nyberg,et al.  Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's con‐tracture and histocompatibility B7 cross‐reacting antigens , 1982 .

[44]  J. V. Vande Berg,et al.  Cell culture of Peyronie's disease plaque and normal penile tissue. , 1982, The Journal of urology.

[45]  M. Willscher,et al.  The association of histocompatibility antigens of the B7 cross-reacting group with Peyronie's disease. , 1979, The Journal of urology.

[46]  J. Byström,et al.  Induratio penis plastica Peyronie's disease. Clinical features and etiology. , 1976, Scandinavian journal of urology and nephrology.

[47]  J. Williams,et al.  The natural history of Peyronie's disease. , 1970, The Journal of urology.

[48]  B. H. Smith,et al.  Peyronie's disease. , 1966, American journal of clinical pathology.

[49]  R. Ling.  THE GENETIC FACTOR IN DUPUYTREN'S DISEASE. , 1963, The Journal of bone and joint surgery. British volume.

[50]  C. Furey.  Peyronie's disease: treatment by the local injection of meticortelone and hydrocortisone. , 1957, The Journal of urology.